These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 30582489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG, Muluk NB, Kar M, Cingi C.
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Simon RA.
    Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
    [Abstract] [Full Text] [Related]

  • 11. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR, Ayars AG, Altman MC, Henderson WR.
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [Abstract] [Full Text] [Related]

  • 12. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH.
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [Abstract] [Full Text] [Related]

  • 13. An update on the epidemiology of aspirin-exacerbated respiratory disease.
    White AA.
    Am J Rhinol Allergy; 2017 Sep 01; 31(5):299-301. PubMed ID: 28859704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK, Wenzel SE, Lockey RF.
    J Allergy Clin Immunol Pract; 2014 Sep 01; 2(6):653-7. PubMed ID: 25439353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA, Stevenson DD, Simon RA.
    Ann Allergy Asthma Immunol; 2005 Oct 01; 95(4):330-5. PubMed ID: 16279562
    [Abstract] [Full Text] [Related]

  • 19. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC, Moreno-Paz FJ, Terán LM, Guaní-Guerra E.
    Respir Med; 2018 Feb 01; 135():62-75. PubMed ID: 29414455
    [Abstract] [Full Text] [Related]

  • 20. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R, Świerczyńska-Krępa M, Niżankowska-Mogilnicka E, Holtappels G, De Ruyck N, Sanak M, Derycke L, Van Crombruggen K, Bachert C, Pérez-Novo CA.
    Cytokine; 2016 Jan 01; 77():157-67. PubMed ID: 26615369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.